このエントリーをはてなブックマークに追加
ID 36269
本文ファイル
Thumnail k6214_3.pdf 2.92 MB
Thumnail k6214_1.pdf 180 KB
Thumnail k6214_2.pdf 154 KB
別タイトル
RASEFは肺癌の新たな診断マーカー及び治療標的である
著者
尾下 豪人
キーワード
oncogenes
cancer antigen
biomarker
therapeutic target
lungcancer
NDC
医学
抄録(英)
Genome-wide gene expression profile analyses revealed that Ras and EF-hand domain containing (RASEF) was significantly transactivated in the majority of lung cancers. Transient expression of RASEF promoted cell growth, whereas transfection of siRNA for RASEF to lung cancer cells reduced its expression and resulted in growth suppression of the cancer cells. Immunohistochemical staining using tumor tissue microarrays consisting of 341 archived non-small cell lung cancers revealed the association of strong RASEF positivity with poor prognosis (P = 0.0034 by multivariate analysis). RASEF could bind to extracellular signal-regulated kinase (ERK) 1/2 and appeared to enhance the ERK1/2 signaling. In addition, inhibition of interaction between RASEF and ERK1/2 using cell-permeable peptide that corresponded to the ERK1/2-interacting site of RASEF protein, suppressed growth of lung cancer cells. RASEF may play important roles in lung carcinogenesis, and could be useful as a prognostic biomarker and a target for the development of new molecular therapies.
作成年月日
2014-11-21
言語
英語
NII資源タイプ
学位論文
広大資料タイプ
学位論文
DCMIタイプ
text
フォーマット
application/pdf
著者版フラグ
ETD
権利情報
Copyright(c) by Author
関連情報(references)
Hideto Oshita, Ryohei Nishino, Atsushi Takano, Takashi Fujitomo, Masato Aragaki, Tatsuya Kato, Hirohiko Akiyama, Eiju Tsuchiya, Nobuoki Kohno, Yusuke Nakamura, Yataro Daigo; RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer; Molecular Cancer Research, Published OnlineFirst May 16, 2013. (doi: 10.1158/1541-7786.MCR-12-0685-T)
関連情報URL(references)
http://dx.doi.org/10.1158/1541-7786.MCR-12-0685-T
学位記番号
甲第6214号
授与大学
広島大学(Hiroshima University)
学位名
博士(医学)
学位名の英名
Philosophy in Medical Science
学位の種類の英名
doctoral
学位授与年月日
2013-09-05
部局名
医歯薬学総合研究科